Home › Research › Topics › phosphorylated-tau-217
phosphorylated-tau-217
2 studies tagged phosphorylated-tau-217, dated 2023-03-11 to 2025-10-07. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Plasma phosphorylated tau-217 correlates with brain atrophy, cognition, and cerebrospinal fluid biomarkers in a cognitively healthy community cohort 2025-10-07
- Sensitive label-free detection of the biomarker phosphorylated tau-217 protein in Alzheimer's disease using a graphene-based solution-gated field effect transistor 2023-03-11
Studies
2 studies carry this tag.
Date range
2023 to 2025
Top journals
- Biosensors & bioelectronics 1
- Brain communications 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
We examined if plasma biomarkers of AD, neurodegeneration, and neuroinflammation were associated with cognition, brain structure, and their cerebrospinal fluid (CSF) counterparts in dementia-free older adults.
-
Alzheimer's disease (AD) is generally diagnosed using advanced imaging, but recent research suggests early screening using biomarkers in peripheral blood is feasible; among them, plasma tau proteins phosphorylated at threonine 231, threonine 181, and threonine 217 (p-tau217) are potential targets.